Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 134, Issue 8
August 22 2019
Issue Cover

Table of Contents

BLOOD COMMENTARY

THROMBOSIS AND HEMOSTASIS
Ticks provide insight into human coagulation
Jeremy P. Wood
View Articletitled, Ticks provide insight into human coagulation

BLOOD SPOTLIGHT

ETV6-related thrombocytopenia and leukemia predisposition
Jorge Di Paola,Christopher C. Porter
View Articletitled, ETV6-related thrombocytopenia and leukemia predisposition
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
Clinical Trials & Observations
Saad Z. Usmani,Hareth Nahi,Maria-Victoria Mateos,Niels W. C. J. van de Donk,Ajai Chari,Jonathan L. Kaufman,Philippe Moreau,Albert Oriol,Torben Plesner,Lotfi Benboubker,Peter Hellemans,Tara Masterson,Pamela L. Clemens,Man Luo,Kevin Liu,Jesus San-Miguel
View Articletitled, Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
Supplemental data
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Clinical Trials & Observations
Justin Taylor,Michael Haddadin,Vivek A. Upadhyay,Erwin Grussie,Neha Mehta-Shah,Andrew M. Brunner,Abner Louissaint, Jr,Scott B. Lovitch,Ahmet Dogan,Amir T. Fathi,Richard M. Stone,Martin S. Tallman,Raajit K. Rampal,Donna S. Neuberg,Kristen E. Stevenson,Steven M. Horwitz,Andrew A. Lane
View Articletitled, Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Supplemental data

LYMPHOID NEOPLASIA

Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Brian Giacopelli,Qiuhong Zhao,Amy S. Ruppert,Akwasi Agyeman,Christoph Weigel,Yue-Zhong Wu,Madelyn M. Gerber,Kari G. Rabe,Melissa C. Larson,Junyan Lu,James S. Blachly,Kerry A. Rogers,William G. Wierda,Jennifer R. Brown,Kanti R. Rai,Michael Keating,Laura Z. Rassenti,Thomas J. Kipps,Thorsten Zenz,Tait D. Shanafelt,Neil E. Kay,Lynne V. Abruzzo,Kevin R. Coombes,Jennifer A. Woyach,John C. Byrd,Christopher C. Oakes
View Articletitled, Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition
Viviane S. De Paula,Nikolaos G. Sgourakis,Ivo M. B. Francischetti,Fabio C. L. Almeida,Robson Q. Monteiro,Ana Paula Valente

There is a Blood Commentary on this article in this issue.

View Articletitled, NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition
Supplemental data

LETTERS TO BLOOD

Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis
Wei Jian Tan,Mona Meng Wang,Paola Ricciardi-Castagnoli,Tiffany Tang,Soon Phaik Chee,Tong Seng Lim,Anita Sook Yee Chan
View Articletitled, Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis
Supplemental data
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
Fotini Vogiatzi,Dorothee Winterberg,Lennart Lenk,Swantje Buchmann,Gunnar Cario,Martin Schrappe,Matthias Peipp,Paulina Richter-Pechanska,Andreas E. Kulozik,Jana Lentes,Anke K. Bergmann,Thomas Valerius,Fabian-Simon Frielitz,Christian Kellner,Denis M. Schewe
View Articletitled, Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
Supplemental data

BLOOD WORK

Cutaneous composite small lymphocytic lymphoma and primary cutaneous follicle center lymphoma
Huan-You Wang,Brian R. Hinds
View Articletitled, Cutaneous composite small lymphocytic lymphoma and primary cutaneous follicle center lymphoma
Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement
Marie-Charlotte Bourrienne,Jérôme Debus
View Articletitled, Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement

ERRATUM

Steele AJ, Prentice AG, Hoffbrand AV, et al. 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood. 2009;114(6):1217-1225.
View Articletitled, Steele AJ, Prentice AG, Hoffbrand AV, et al. 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. <em>Blood</em>. 2009;114(6):1217-1225.
All Issues

Advertisement intended for health care professionals

HLA-I aberrations in cutaneous T-cell lymphoma
Daratumumab for maintenance in myeloma
Combined targeted modality in cHL: a risky bet?
Is it time to screen for multiple myeloma?
B-1 B cells lose self-control in SCD

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals